SynthesisInternational journal of molecular sciences2021

FLT3 Tyrosine Kinase Inhibitors for the Treatment of Fit and Unfit Patients with FLT3-Mutated AML: A Systematic Review.

Michael Loschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.